GROUP ONE TRADING, L.P. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$481,509
+43.3%
160,503
+17.5%
0.00%
+100.0%
Q2 2023$335,925
+240.2%
136,555
+212.5%
0.00%
Q1 2023$98,748
-80.3%
43,694
-69.6%
0.00%
-100.0%
Q4 2022$500,937
+682.7%
143,535
+4179.5%
0.00%
Q2 2022$64,000
+20.8%
3,354
+64.8%
0.00%
Q3 2021$53,000
-77.1%
2,035
-71.8%
0.00%
Q2 2021$231,000
+5.5%
7,220
+16.1%
0.00%
Q1 2021$219,0006,2200.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders